Enalapril Prevents Impaired Nitric Oxide Synthase-Dependent Dilatation of Cerebral Arterioles in Diabetic Rats

Stroke

Volumn 34, Issue 11, 2003, Pages 2698-2703

  Trauernicht, Anna K ^a   Sun, Hong ^a   Patel, Kaushik P ^a   Mayhan, William G ^a  

^a 984575 Nebraska Medical Center ^*

Author keywords

Acetylcholine; Adenosine; Angiotensin converting enzyme inhibitors; Brain; Nitric oxide; Nitroglycerin; Rats; Stroke

Indexed keywords

ACETYLCHOLINE; ADENOSINE DIPHOSPHATE; ENALAPRIL; GLUCOSE; NITRIC OXIDE SYNTHASE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL REACTIVITY; BODY WEIGHT; BRAIN ARTERY; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PIA ARTERY; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; VASODILATATION; WESTERN BLOTTING;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ARTERIOLES; BRAIN; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ENALAPRIL; MALE; MICROCIRCULATION; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR PATENCY; VASODILATION; VASODILATOR AGENTS;

EID: 0242694051     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000092121.62649.DC     Document Type: Article

References (35)

1. Lieberman J, Sastre A. Serum angiotensin-converting enzyme: elevations in diabetes mellitus. Ann Intern Med. 1980;93:825-826.
2. Duntas L, Keck FS, Haug C, Hetzel W, Wolf CF, Rosenthal J, Pfeiffer EF. Serum angiotensin-converting enzyme activity and active renin plasma concentrations in insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1992;16:203-208.
3. Schernthaner G, Schwarzer C, Kuzmits R, Muller MM, Klemen U, Freyler H. Increased angiotensin-converting enzyme activities in diabetes mellitus: analysis of diabetes type, state of metabolic control and occurrence of diabetes vascular disease. J Clin Pathol. 1984;37:307-312.
4. O'Driscoll G, Green D, Rankin J, Stanton K, Taylor R. Improvement in endothelial function by angiotensin converting enzyme inhibition to insulin-dependent diabetes mellitus. J Clin Invest. 1997;100:678-684.
5. Cheetham C, Collis J, O'Driscoll G, Stanton K, Taylor R, Green D. Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes. J Am Coll Cardiol. 2000;36:1461-1466.
6. O'Driscoll G, Green D, Maiorana A, Stanton K, Colreavy F, Taylor R. Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1999;33:1506-1511.
7. Arcaro G, Zenere BM, Saggiani F, Zenti MG, Monauni T, Lechi A, Muggeo M, Bonadonna RC. ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care. 1999;22:1536-1542.
8. Torlone E, Britta M, Rambotti AM, Perriello G, Santeusanio F, Brunetti P, Bolli GB. Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes. Diabetes Care. 1993;16:1347-1355.
9. Cachofeiro V, Sakakibara T, Nasjletti A. Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension. Hypertension. 1992;19:138-145.
10. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations in vascular tone. J Clin Invest. 1996;97:1916-1923.
11. de Cavanagh EMV, Inserra F, Toblli J, Stella I, Fraga CG, Ferder L. Enalapril attenuates oxidative stress in diabetic rats. Hypertension. 2001;38:1130-1136.
12. Rajagopalan S, Harrison DG. Reversing endothelial dysfunction with ACE inhibitors: a new trend. Circulation. 1996;94:240-243.
13. Gonzalez Bosc LV, Kurnjek ML, Muller A, Terragno NA, Basso N. Effect of chronic angiotensin II inhibition on the nitric oxide synthase in the normal rat during aging. J Hypertens. 2001;19:1403-1409.
14. Cooper ME, Gilbert RE, Jerums G. Diabetic vascular complications. Clin Exp Pharmacol Physiol. 1997;24:770-775.
15. Mortel KF, Meyer JS, Sims PA, McClintic K. Diabetes mellitus as a risk factor for stroke. South Med J. 1990;83:904-911.
16. Pelligrino DA, Koenig HM, Wang Q, Albrecht RF. Protein kinase C suppresses receptor-mediated pial arteriolar relaxation in the diabetic rat. Neuroreport. 1994;5:417-420.
17. Fujii K, Heistad DD, Faraci FM. Effect of diabetes mellitus on flow-mediated and endothelium-dependent dilatation of the rat basilar artery. Stroke. 1992;23:1494-1498.
18. Mayhan WG. Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus. Am J Physiol. 1989;256: H621-H625.
19. Mayhan WG. Impairment of endothelium-dependent dilatation of the basilar artery during diabetes mellitus. Brain Res. 1992;580:297-302.
20. Mayhan WG, Simmons LK, Sharpe GM. Mechanism of impaired responses of cerebral arterioles during diabetes mellitus. Am J Physiol. 1991;260:H319-H326.
21. Mayhan WG. Superoxide dismutase partially restores impaired dilatation of the basilar artery during diabetes mellitus. Brain Res. 1997;760:204-209.
22. Ogiku N, Sumikawa H, Hasimoto Y, Ishida R. Prophylactic effect of imidapril on stroke in stroke-prone spontaneously hypertensive rats. Stroke. 1993;24:245-252.
23. Mayhan WG, Heistad DD. Permeability of blood-brain barrier to various sized molecules. Am J Physiol. 1985;248:H712-H718.
24. McNeill AM, Kim N, Duckles SP, Krause DN. Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke. 1999;30:2186-2190.
25. Sun H, Patel KP, Mayhan WG. Tetrahydrobiopterin, a cofactor for NOS, improves endothelial dysfunction during chronic alcohol consumption. Am J Physiol. 2001;281:H1863-H1869.
26. Sun H, Patel KP, Mayhan WG. Impairment of neuronal nitric oxide synthase-dependent dilatation of cerebral arterioles during chronic alcohol consumption. Alcohol Clin Exp Res. 2002;26:663-670.
27. Mayhan WG. Endothelium-dependent responses of cerebral arterioles to adenosine 5′-diphosphate. J Vasc Res. 1992;29:353-358.
28. Faraci FM. Role of endothelium-derived relaxing factor in cerebral circulation: large arteries vs. microcirculation. Am J Physiol. 1991;261: H1038-H1042.
29. Xu HL, Feinstein DL, Santizo RA, Koenig HM, Pelligrino DA. Agonist-specific differences in mechanisms mediating eNOS-dependent pial arteriolar dilation in rats. Am J Physiol. 2002;282:H237-H243.
30. Mukai Y, Shimokawa H, Higashi M, Morikawa K, Matoba T, Hiroki J, Kunihiro I, Talukder HM, Takeshita A. Inhibition of renin-angiotensin system ameliorates endothelial dysfunction associated with aging in rats. Arterioscler Thromb Vasc Biol. 2002;22:1445-1450.
31. De Gennaro Colonna V, Rossoni G, Rigamonti A, Bonomo S, Manfredi B, Berti F, Muller E. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats. Eur J Pharmacol. 2002;450:61-66.
32. Ohara Y, Sayegh HS, Yamin JJ, Harrison DG. Regulation of endothelial constitutive nitric oxide synthase by protein kinase C. Hypertension. 1995;25:415-420.
33. Harrison DG, Venema RC, Arnal JF, Inoue N, Ohara Y, Sayegh H, Murphy TJ. The endothelial cell nitric oxide synthase: is it really constitutively expressed? Agents Actions Suppl. 1995;45:107-117.
34. Fukai T, Folz RJ, Landmesser U, Harrison DG. Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res. 2002;55:239-249.
35. Hink U, Li H, Mollnau H, Oelse M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RAK, Warnholtz A, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 2001;88:e14-e22.